AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Meitav Investment House Ltd.

Interim / Quarterly Report Aug 17, 2025

6912_rns_2025-08-17_f1b5042a-6620-4045-a876-20b1b3b60c1b.pdf

Interim / Quarterly Report

Open in Viewer

Opens in native device viewer

This document is a partial unofficial translation for convenience only of the Hebrew original of the financial report of Meitav Investment House Ltd. as of June 30, 2025, that was submitted to the Tel-Aviv Stock Exchange and the Israeli Securities Authority on August 17, 2025. The Hebrew version submitted to the TASE and the Israeli Securities Authority shall be the sole legally binding version. For the details of the policy, see the Company's immediate report dated August 19, 2024 (reference number: 2024-01-08-4447)

MEITAV INVESTMENT HOUSE LTD.

CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS

AS OF JUNE 30, 2025

INDEX

Page
Consolidated Statements of Financial Position 2
-
3
Consolidated Statements of Profit or Loss and Other Comprehensive Income 4
Consolidated Statements of Changes in Equity 5
-
9
Consolidated Statements of Cash Flows 10
-
12

CONSOLIDATED STATEMENTS OF FINANCIAL POSITION

June
30,
2025 2024 December 31,
2024
Unaudited
NIS in millions
ASSETS
CURRENT ASSETS:
Cash and cash equivalents 355 281 205
Short-term investments 271 639 324
Customer credit 2,124 1,733 1,977
Trade receivables 123 78 105
Other accounts receivable 268 72 130
Current taxes receivable 8 16 8
3,149 2,819 2,749
NON-CURRENT ASSETS:
Investments of provident fund members 107 102 103
Investments, loans and receivables 1,122 934 1,002
Investments in associates 21 60 22
Fixed assets 172 168 172
Deferred taxes 79 61 79
Intangible assets 1,401 1,287 1,350
2,902 2,612 2,728
6,051 5,431 5,477

CONSOLIDATED STATEMENTS OF FINANCIAL POSITION

June
30,
December 31,
2025 2024 2024
Unaudited Audited
NIS in millions
LIABILITIES AND EQUITY
CURRENT LIABILITIES:
Credit from banks and other credit providers 2,066 1,979 1,910
Liabilities for short sale of securities 76 45 91
Trade payables 140 114 134
Other accounts payable 389 236 251
Provisions for legal claims 695 658 676
Current taxes payable 43 36 54
3,409 3,068 3,116
NON-CURRENT LIABILITIES:
Debentures 678 609 477
Credit from banks and other credit providers 576 423 484
Liabilities to provident fund members 112 109 109
Lease liabilities 131 126 134
Employee benefit liabilities 6 6 6
Deferred taxes 35 34 34
1,538 1,307 1,244
Total liabilities 4,947 4,375 4,360
EQUITY:
Share capital 77 77 77
Share premium 620 635 635
Capital reserve for share-based payment transactions 52 46 48
Retained earnings 322 133 222
Other reserves (144) (103) (134)
Equity attributable to equity holders of the Company 927 788 848
Non-controlling interests 177 268 269
Total equity 1,104 1,056 1,117
6,051 5,431 5,477
August 14, 2025
Date of approval of the Eli Barkat Ilan Raviv Einat Rom
financial statements Chairman of the Board CEO CFO

CONSOLIDATED STATEMENTS OF PROFIT OR LOSS AND OTHER COMPREHENSIVE INCOME

Six months ended
Three months ended
June 30,
June 30,
Year ended
December 31,
2025 2024 2025 2024 2024
Unaudited Audited
NIS in millions (except per share data)
Revenue from management fees,
commissions and other, net
739 613 379 316 1,301
Income from non-bank loans activity 189 152 98 89 318
Total revenues 928 765 477 405 1,619
Income refund in respect of legal claims against the
Company - - - - (2)
Total revenues 928 765 477 405 1,617
Marketing, operating, general and administrative
expenses 544 484 275 243 1,004
Finance expenses on non-bank loans 76 60 38 32 134
Operating income 308 221 164 130 479
Gain (loss) from securities held for investment purposes
in nostro portfolio, net 11 5 6 (1) 12
Finance income 4 12 1 6 20
Finance expenses (38) (46) (23) (28) (85)
Other income (expenses), net (4) - 1 2 (6)
Company's share of losses of companies accounted for at
equity, net - (25) - (19) (27)
Income before taxes on income 281 167 149 90 393
Taxes on income 72 44 41 24 103
Net income for the period 209 123 108 66 290
Other comprehensive income (net of tax effect):
Foreign currency translation adjustments of foreign
operations 1 1 - 1 (1)
Total other comprehensive income 1 1 - 1 (1)
Total comprehensive income 210 124 108 67 289
Net income attributable to:
Equity holders of the Company 185 108 95 58 256
Non-controlling interests 24 15 13 8 34
209 123 108 66 290
Comprehensive income attributable to:
Equity holders of the Company 186 109 95 59 255
Non-controlling interests 24 15 13 8 34
210 124 108 67 289
Basic and diluted net earnings per share attributable to
equity holders of the Company (in NIS):
Basic net earnings 2.35 1.38 1.21 0.74 3.26
Diluted net earnings 2.35 1.38 1.21 0.74 3.26
Attributable to equity holders of the Company
Share
capital
Share
premium
Capital
reserve from
share-based
payment
transactions
Retained
earnings
Other
reserves
Total Non
controlling
interests
Total
equity
Unaudited
NIS in millions
Balance at January 1, 2025 (audited) 77 635 48 222 (134) 848 269 1,117
Net income for the period
Other comprehensive income, net
-
-
-
-
-
-
185
-
-
1
185
1
24
-
209
1
Total comprehensive income
Dividend declared and paid
Dividend to non-controlling interests
Net purchases of non-controlling interests
-
-
-
-
-
-
-
-
-
-
-
-
185
(85)
-
-
1
-
-
(9)
186
(85)
-
(9)
24
-
(18)
(111)
210
(85)
(18)
(120)
Exercise of options in a subsidiary
Share-based payment
Repurchase of the Company's shares
-
-
*) -
-
-
(15)
-
4
-
-
-
-
(2)
-
-
(2)
4
(15)
10
3
-
8
7
(15)
Balance at June 30, 2025 77 620 52 322 (144) 927 177 1,104

*) Less than NIS 1 million.

Attributable to equity holders of the Company
Share
capital
Share
premium
Capital
reserve from
share-based
payment
transactions
Retained
earnings
Other
reserves
Total Non
controlling
interests
Total
equity
Unaudited
NIS in millions
Balance at January 1, 2024
(audited)
77 635 42 85 (117) 722 229 951
Net income for the period
Other comprehensive income, net
-
-
-
-
-
-
108
-
-
1
108
1
15
-
123
1
Total comprehensive income
Dividend declared and paid
Dividend to non-controlling interests
-
-
-
-
-
-
-
-
-
108
(60)
-
1
-
-
109
(60)
-
15
-
(11)
124
(60)
(11)
Issue of capital and options to non-controlling
interests (net of issuance expenses)
Share-based payment
-
-
-
-
-
4
-
-
15
-
15
4
34
2
49
6
Derecognition of non-controlling interests due to
sale of subsidiary
Net purchases of non-controlling interests
-
-
-
-
-
-
-
-
-
(2)
-
(2)
(1)
-
(1)
(2)
Balance at June 30, 2024 77 635 46 133 (103) 788 268 1,056
Attributable to equity holders of the Company
Share
capital
Share
premium
Capital
reserve from
share-based
payment
transactions
Retained
earnings
Unaudited
Other
reserves
Total
Non
controlling
interests
Total
equity
NIS in millions
Balance at April 1, 2025 77 631 49 262 (130) 889 276 1,165
Net income for the period
Other comprehensive income, net
-
-
-
-
-
-
95
-
-
-
95
-
13
-
108
-
Total comprehensive income
Dividend declared and paid
Dividend to non-controlling interests
-
-
-
-
-
-
-
-
-
95
(35)
-
-
-
-
95
(35)
-
13
-
(10)
108
(35)
(10)
Share-based payment
Exercise of options in a subsidiary
Net purchases of non-controlling interests
Repurchase of the Company's shares
-
-
-
*) -
-
-
-
(11)
3
-
-
-
-
-
-
-
-
(5)
(9)
-
3
(5)
(9)
(11)
2
7
(111)
-
5
2
(120)
(11)
Balance at June 30, 2025 77 620 52 322 (144) 927 177 1,104

*) Less than NIS 1 million.

Attributable to equity holders of the Company
Share
capital
Share
premium
Capital
reserve from
share-based
payment
transactions
Retained
earnings
Other
reserves
Total Non
controlling
interests
Total
equity
Unaudited
NIS in millions
Balance at April 1, 2024 77 635 44 90 (104) 742 268 1,010
Net income for the period
Other comprehensive income, net
-
-
-
-
-
-
58
-
-
1
58
1
8
-
66
1
Total comprehensive income
Dividend declared and paid
Dividend to non-controlling interests
Share-based payment
Derecognition of non-controlling interests due to
sale of subsidiary
-
-
-
-
-
-
-
-
-
-
-
-
-
2
-
58
(15)
-
-
-
1
-
-
-
-
59
(15)
-
2
-
8
-
(7)
-
(1)
67
(15)
(7)
2
(1)
Balance at June 30, 2024 77 635 46 133 (103) 788 268 1,056
Attributable to equity holders of the Company
Capital
reserve from
share-based
Non
Share
capital
Share
premium
payment
transactions
Accumulated
earnings
Other
reserves
Total controlling
interests
Total
equity
Audited
NIS in millions
Balance at January 1, 2024 77 635 42 85 (117) 722 229 951
Net income for the period - - - 256 - 256 34 290
Other comprehensive income, net - - - - (1) (1) - (1)
Total comprehensive income - - - 256 (1) 255 34 289
Dividend declared and paid - - - (119) - (119) - (119)
Dividend to non-controlling interests - - - - - - (21) (21)
Issue of capital and options to non-controlling
interests (net of issuance expenses) - - - - 15 15 34 49
Share-based payment - - 6 - - 6 7 13
Net purchases of non-controlling interests - - - - 2 2 (13) (11)
Transaction with non-controlling interest in an
associate
- - - - (33) (33) - (33)
Derecognition of non-controlling interests due to
sale of subsidiary
- - - - - - (1) (1)
Balance at December 31, 2024 77 635 48 222 (134) 848 269 1,117

CONSOLIDATED STATEMENTS OF CASH FLOWS

Six months ended
June 30,
Three months ended
June 30,
Year ended
December 31,
2025 2024 2025 2024 2024
Unaudited NIS in millions Audited
Cash flows from operating activities:
Net income for the period 209 123 108 66 290
Adjustments to reconcile net income to
net cash provided by operating
activities:
Adjustments to the profit or loss items:
Depreciation of fixed assets 16 15 8 6 31
Amortization of intangible assets 32 29 17 15 60
Gain from sale of investment in
consolidated subsidiary
- (3) - (3) (3)
Amortization of deferred acquisition costs 31 21 16 11 48
Revaluation of investments to provident
fund members (4) (2) (4) (1) (3)
Revaluation of liabilities to provident
fund members 3 4 2 2 4
Company's share of losses of companies
accounted for at equity, net - 25 - 19 27
Deferred taxes, net 1 (14) 4 (12) (32)
Revaluation of debentures 2 5 1 4 9
Gains from securities measured at fair
value through profit or loss, net (22) (20) (16) (6) (39)
Change in short-term deposits 1 (5) 2 4 -
Share-based payment 7 6 5 2 13
67 61 35 41 115
Changes in asset and liability items:
Customer credit, trade receivables and
other accounts receivable (423) (513) (334) (421) (899)
Short-term credit from giving non-bank
loans
95 358 104 357 594
Trade payables, provisions for legal
claims and other accounts payable
68 (53) (9) (33) (75)
(260) (208) (239) (97) (380)
Net cash provided by (used in) operating
activities 16 (24) (96) 10 25

CONSOLIDATED STATEMENTS OF CASH FLOWS

Six months ended
June 30,
Three months ended
June 30,
Year ended
December 31,
2025 2024 2025 2024 2024
Unaudited Audited
NIS in millions
Cash flows from investing activities:
Sale (purchase) of short-term investments
measured at fair value through profit or
loss 66 (4) 36 (35) 13
Purchase of fixed assets (4) (8) (1) (6) (12)
Purchase of intangible assets
Repayment of restricted deposit
(25)
-
(29)
-
(13)
-
(15)
-
(59)
352
Change in restricted deposits, net 10 42 (1) 21 23
Investments and
loans to companies
accounted for at equity - (4) 6 (3) -
Repayment of long-term loans - - - - 6
Sale of investments in subsidiaries (b) - 1 - 1 1
Net cash provided by (used in) investing
activities 47 (2) 27 (37) 324
Cash flows from financing activities:
Repayment of Company debentures - - - - (135)
Receipt of long-term loans from banks 85 125 85 69 173
Issue of subsidiary's debentures 199 - 199 - -
Repayment of subsidiary's debentures - (148) - (74) (148)
Issuance of capital
and options to non
controlling interests
(net of issuance
costs) - 49 - - 49
Dividend paid to the shareholders of the
Company (85) (60) (85) (60) (119)
Dividend paid to non-controlling interests (18) (11) (13) (7) (21)
Repayment of long-term lease liabilities (16) (11) (8) (5) (25)
Purchases of non-controlling interests
,net
(120) (7) (120) - (18)
Repurchase of the Company's shares
Repurchase of subsidiary's shares by the
(15) - (11) - -
subsidiary - (1) - - (1)
Exercise of options in a subsidiary 8 - 2 - -
Proceeds from short sale (purchase) of
securities, net (16) (16) (17) (15) 10
Receipt of loans from other credit providers 2 - 2 - 12
Short-term credit from banks, net 63 68 116 52 (240)
Net cash provided by (used in) financing
activities 87 (12) 150 (40) (463)
Effect of exchange rate changes on cash and
cash equivalents - - (1) - -
Increase (decrease) in cash and cash
equivalents
Cash and cash equivalents at the beginning
150 (38) 80 (67) (114)
of the period 205 319 275 348 319
Cash and cash equivalents at the end of the
period 355 281 355 281 205

CONSOLIDATED STATEMENTS OF CASH FLOWS

Six months ended
June 30,
Three months ended
June 30,
Year ended
December 31,
2025 2024 2025 2024 2024
Unaudited Audited
NIS in millions
(a) Additional information on cash flows
from operating activities:
Cash paid during the period for:
Interest 41 56 28 30 108
Taxes on income 68 77 24 25 130
Cash received during the period for:
Interest 149 181 81 124 393
Taxes on income 3 - - - 11
(b) Sale of investments in subsidiaries:
Working capital (excluding cash and
cash equivalents)
- (2) - (2) (2)
Total assets and liabilities of the
subsidiary on date of sale - (2) - (2) (2)
Capital gain from sale of subsidiaries - 3 - 3 3
- 1 - 1 1

Talk to a Data Expert

Have a question? We'll get back to you promptly.